Skip to content Skip to navigation

Additional Ventures support for single ventricle heart disease research

The Loh and Rabinovitch laboratories received new support from Additional Ventures and the Stanford Maternal and Child Health Research Institute to study single-ventricle heart disease, using pluripotent stem cell technology.